Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Other Non-Current Liabilities (2012 - 2025)

Verastem (VSTM) posted quarterly Other Non-Current Liabilities of $35.6 million for Q4 2025, down 38.75% year-over-year from $58.2 million in Q4 2024, and down 26.18% quarter-over-quarter from $48.3 million in Q3 2025.

Analysis

Verastem (VSTM) Other Non-Current Liabilities (2012 - 2025) Analysis & Trends

Verastem's Other Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $35.6 million for Q4 2025.

  • In Q4 2025, Other Non-Current Liabilities fell 38.75% year-over-year to $35.6 million; the TTM figure through Dec 2025 stood at $35.6 million (down 38.75% YoY), while the FY2025 annual figure was $35.6 million, down 38.75% from the prior year.
  • Other Non-Current Liabilities for Q4 2025 stood at $35.6 million, down from $48.3 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $58.2 million in Q4 2024, with the low at $51000.0 in Q3 2023.
  • The 3-year median for Other Non-Current Liabilities is $35.6 million (2025), against an average of $32.9 million.
  • The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities surged 51150.98% in 2024, then plunged 38.75% in 2025.
  • Verastem's Other Non-Current Liabilities stood at $51000.0 in 2023, then surged by 114015.69% to $58.2 million in 2024, then plunged by 38.75% to $35.6 million in 2025.
  • Business Quant data shows VSTM's Other Non-Current Liabilities at $35.6 million in Q4 2025, $48.3 million in Q3 2025, and $7.6 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 35.65 Mn
Sep 30, 2025 48.29 Mn
Jun 30, 2025 21.76 Mn
Mar 31, 2025 54.75 Mn
Dec 31, 2024 58.20 Mn
Sep 30, 2024 26.14 Mn
Sep 30, 2023 51,000.00
Jun 30, 2020 870,000.00
Mar 31, 2020 870,000.00
Dec 31, 2019 870,000.00
Sep 30, 2019 870,000.00
Jun 30, 2019 500,000.00
Mar 31, 2019 500,000.00
Dec 31, 2018 1.12 Mn
Sep 30, 2018 566,000.00
Jun 30, 2018 399,000.00
Mar 31, 2018 101,000.00
Dec 31, 2017 151,000.00
Sep 30, 2017 201,000.00
Jun 30, 2017 248,000.00